FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1078.680

Packageus.nlm.vsac
TypeValueSet
Id2.16.840.1.113762.1.4.1078.680
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.680/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.680
Version20240206
Statusactive
Date2024-02-06T01:09:28-05:00
NameGLP1RADMASCVD
TitleGLP1RA DM ASCVD
Realmus
Authorityhl7
DescriptionExcluded oral form of semaglutide (only Rybelsus)
Purpose(Clinical Focus: Medications containing GLP-RAs that have evidence for benefit in ASCVD (that is, reduction in MACE - major adverse cardiac events) per the ADA Standards of Care in Diabetes 2023),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC:),(Inclusion Criteria: RxCUIs for medications containing one of the following ingredients: * dulaglutide * liraglutide * semaglutide (ONLY subcutaneous form)),(Exclusion Criteria: Excluded oral form of semaglutide)

Resources that use this resource

No resources found

Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource

Source

Error loading source: Cannot read properties of undefined (reading 'div')